SecBot SecBot

AVR

Anteris Technologies Global Corp.
Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies· Inc. DE· CIK 0002011514 Healthcare & Medical Devices
$5.78 −0.09 (−1.53%)
Oct 26 4:00 PM ET · prev $5.87
Market cap
$584.8M
Small cap
Consensus
Buy
88% Buy or better · 8 analysts
Median target
$15.00
+160% · range $10.00–16.00
Next earnings
Nov 10
in 15 days · EPS est. −$0.31
1 year
+10.5%
from $5.23 · Oct 27
30 days
−25.3%
from $7.74
52-week range
$3.38–10.57
−45% from high · low Nov 20
Avg volume 20D
1.49M
shares / day
Short interest
6.67M
≈6.8% of shares · +3.9%
Days to cover
7.7
at average volume
Insider net
+$21.5M
2 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BULLISH 9 reports · 90 days
Balance 1 bearish · 3 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 6/9 ·Next Earnings date, Nov 10, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersMIXED

    2 insiders bought $47.1M at an average $5.97. 1 insider sold $25.6M.

  • InstitutionsBULLISH

    Q2 2026: 22 added (0 new), 9 trimmed or exited.

  • AnalystsBULLISH

    7 of 8 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.247 → −$0.308 over 90 days. 0 up, 2 down in 30 days.

  • Short sellersSTEADY

    Short interest +3.9% to 6.67M shares. 7.7 days to cover, ≈6.8% of shares.

  • TrendDOWNTREND

    26% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
FMR LLCDOUBLED6,868,086$67.7M
STATE STREET CORPADD1,709,198$16.8M
UBS Group AGTRIM752,168$7.4M
CITADEL ADVISORS LLCDOUBLED610,044$6.0M
JPMORGAN CHASE & CODOUBLED324,034$3.2M
PRUDENTIAL FINANCIAL INCDOUBLED244,715$2.4M
Bank of New York Mellon CorpADD232,666$2.3M
BANK OF AMERICA CORP /DE/DOUBLED193,621$1.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

8 analysts
Buy 88% rate it Buy or better
Strong Buy1Buy6Hold1Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +160%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Oct 14, 2026Cantor Fitzgerald
REITERATE
REITERATEOverweight
Oct 7, 2026Barclays
INITIATE
INITIATEEqual-Weight
Aug 14, 2026Cantor Fitzgerald
REITERATE
REITERATEOverweight
May 15, 2026Barclays
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$47.1M
bought · 2 insiders
$25.6M
sold · 1 insider
−3.1%
vs their $5.97 cost
DateInsiderTypeValue
Oct 6, 2026
L1 Capital Pty Ltd
10%+ Owner
BUY$2.0M
Oct 5, 2026
L1 Capital Pty Ltd
10%+ Owner
BUY$4.9M
Oct 2, 2026
L1 Capital Pty Ltd
10%+ Owner
BUY$1.8M
Oct 1, 2026
L1 Capital Pty Ltd
10%+ Owner
BUY$2.5M
Sep 30, 2026
L1 Capital Pty Ltd
10%+ Owner
BUY$573.5K
Sep 11, 2026
Moen Brent
Chief Financial Officer
AWARD90,274 sh
Aug 28, 2026
L1 Capital Pty Ltd
10%+ Owner
SELL$68.9K
Aug 19, 2026
St Denis David
Chief Operating Officer
EXERCISE$339.0K

Earnings setup

Estimates
Nov 10
reports in 15 days
−$0.31
EPS estimate, this quarter
−25%
estimate change, 90 days
0↑ 2↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.31-$0.32–-$0.29+1.8%$3.9M
Next Q-$0.31-$0.32–-$0.29-1.5%$4.2M
Current FY-$1.18-$1.22–-$1.14+1.0%$8.5M
Next FY-$1.15-$1.43–-$0.78-15.4%$14.1M

Short side

FINRA· Sep 30, 2026
6,669,292
shares short
+3.9%
vs prior settlement
7.7
days to cover
≈6.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 6, 2026 SEC
L1 Capital Pty Ltd, a 10% owner of Anteris Technologies Global Corp., made a series of open-market purchases totaling…
INSIDER-BUY — Impact 6/10
Oct 6, 2026 Insider
L1 Capital Pty Ltd bought 272,695 shares
10%+ Owner @ $7.18 ($2.0M)
Oct 5, 2026 Insider
L1 Capital Pty Ltd bought 648,455 shares
10%+ Owner @ $7.51 ($4.9M)
Oct 1, 2026 SEC
A 10% owner, L1 Capital Pty Ltd, purchased $573K of AVR common stock on the open market at $7.72/share on September…
INSIDER-BUY — Impact 5/10
Oct 2, 2026 Insider
L1 Capital Pty Ltd bought 236,354 shares
10%+ Owner @ $7.78 ($1.8M)
Sep 23, 2026 SEC
Anteris Technologies extended its existing Supply & Quality Agreement with Harvey Industries Group Pty Ltd through…
8-K — Impact 2/10
Aug 31, 2026 Other
Anteris to Present at September Healthcare Investor Conferences
Anteris to Present at September Healthcare Investor Conferences - Cantor, Wells Fargo and Morgan Sta
Jun 30, 2026 Inst.
FMR LLC — DOUBLED
6,868,086 shares ($67.7M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Aug 31, 2026
Press release
Anteris to Present at September Healthcare Investor Conferences
Anteris to Present at September Healthcare Investor Conferences - Cantor, Wells Fargo and Morgan Stanley
Aug 11, 2026
Earnings
Anteris Technologies Announces Results for the Second Quarter of 2026
Anteris Technologies Announces Results for the Second Quarter of 2026
Aug 10, 2026
Earnings date
AVR Q2 2026 Earnings Scheduled — 2026-08-10
Jul 15, 2026
Short interest
Short Interest: AVR up 31% to 8.1M shares
Settlement 2026-07-15 | Days to cover: 6.36 | ≈8.29% of shares outstanding (est.)
Jun 8, 2026
Press release
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance

SecBot reports

15 filings · 5 bullish · 4 bearish · 6 neutral
All AVR filing & press-release reports (15)